INTESTINAL TOXICITY OF 5-FLUOROURACIL AND LEUCOVORIN
5-氟尿嘧啶和亚叶酸的肠道毒性
基本信息
- 批准号:3185592
- 负责人:
- 金额:$ 7.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-05-01 至 1991-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This investigation is to examine the toxicity of 5-fluorouracil (FU)
and leucovorin (LV) to intestinal epithelial cells. The antitumor
activity of FU is due to the incorporation of its anabolite 5-
fluorouridine triphosphate (FUTP) into fradulent RNA, and to its
other anabolite 5-fluorodeoxyuridylate (FdUMP) which inhibits the
synthesis of thymidylate and DNA by forming a ternary complex
with the enzyme thymidylate synthase (TS) and the cofactor N-5,
10-methylenetetrahydrofolate (CH2-THF). In some tumor cells,
folate analogues by increasing the intracellular CH2-THF
concentration enhanced the TS inhibition and cytotoxicity of FU.
Phase I-II trials of FU and LV showed that LV significantly
improved the response rate of FU in gastric and colorectal
cancers, but also potentiated its intestinal toxicity. Anticancer
drugs cause intestinal toxicity by inhibiting the mitosis of the
proliferating intestinal epithelial crypt cells. The crypt cell kill
and recovery is determined by the concentration and duration of
tissue exposure to the drug (AUC). The ongoing phase III trials
use 10 vastly different regimens of FU and LV, which produce in
the intestinal cells different drug AUC's and therefore likely
different toxicity to patients. The objectives of this study are to
examine the cellular metabolism, pharmacodynamics and
mechanism of FU toxicity to the intestinal crypt cells, and the
interaction between FU and folates. Preliminary studies, using
our newly established cultured intestinal crypt (RIEC) cells
derived from normal adult rats, showed that FU was incorporated
into RNA, inhibited DNA synthesis and cell growth. The following
studies will be done using the RIEC cells. 1. Define the
relationship between the cytotoxicity and the AUC of FU alone
and FU-folates, using the therapeutic/toxic AUC's from phase III
FU-LV protocols. 2. Establish the mechanism of FU toxicity by
examining its intracellular metabolism, DNA (inhibition of DNA
synthesis) and RNA (incorporation into RNA) effcts, and the
modulation of its activity by thymidine and uridine. 3. Compare
the kinetics of TS inhibition with those of FdUMP and dUMP. 4.
Assess the effects of folates. The proposed studies are expected
to illustrate the pharmacology of FU and folates in the intestinal
crypt cells, and the reversibility of drug toxicity by thymidine
and/or uridine. The comparative cytotoxicity of different AUC's
of FU-folates may indicate the relative intestinal toxicity of the
different phase III FU-LV regimens.
本研究旨在检测5-氟尿嘧啶(FU)的毒性。
和亚叶酸钙(LV)对肠上皮细胞的作用。抗肿瘤药物
FU的活性是由于其合成代谢产物5-氟尿嘧啶的结合。
将三磷酸氟尿苷(FUTP)转化为FUTP,并将其转化为FUTP
其他合成代谢产物5-氟脱氧尿苷(FdUMP),它抑制
三元络合物合成胸苷和DNA
在胸苷合成酶(TS)和辅因子N-5的作用下,
10-亚甲基四氢叶酸(CH2-THF)。在一些肿瘤细胞中,
增加细胞内CH2-THF的叶酸类似物
浓度可增强FU对TS的抑制作用和细胞毒作用。
FU和LV的I-II期试验显示LV显著
提高FU在胃、结直肠的有效率
但也增强了它的肠道毒性。抗癌
药物通过抑制细胞有丝分裂而引起肠道毒性
增殖的肠上皮隐窝细胞。隐窝细胞杀伤力
而回收率则取决于浓度和持续时间。
组织暴露于药物(AUC)。正在进行的第三阶段试验
使用10种截然不同的FU和LV方案,这两种方案在
肠道细胞不同的药物AUC,因此很可能
对患者有不同的毒性。这项研究的目的是
检查细胞代谢、药效学和
氟尿嘧啶对肠道隐窝细胞的毒性机制
氟尿嘧啶与叶酸的相互作用。初步研究,使用
我们新建立的培养的肠腺(RIEC)细胞
取自正常成年大鼠,表明FU被掺入
转化为RNA,抑制DNA合成和细胞生长。以下是
研究将使用RIEC细胞进行。1.定义
单药氟尿嘧啶的细胞毒性与AUC的关系
和氟叶酸,使用III期的治疗性/毒性AUC
FU-LV协议。2.通过以下途径建立FU的毒性机制
检测其细胞内代谢,DNA(DNA抑制
合成)和RNA(结合到RNA中)的效果,以及
胸苷和尿苷对其活性的调节。3.比较
TS的抑制动力学与FdUMP和DUMP相同。4.
评估叶酸的影响。拟议的研究是可望完成的
说明氟尿嘧啶和叶酸在肠道的药理作用
隐窝细胞和胸腺嘧啶核苷对药物毒性的可逆性
和/或尿苷。不同AUC的细胞毒性比较
FU-叶酸的相对肠道毒性可能表明
不同的III期FU-LV方案。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.
尿苷联合给药对大鼠 5-脱氧-5-氟尿苷处置的影响。
- DOI:10.1007/bf00254172
- 发表时间:1988
- 期刊:
- 影响因子:3
- 作者:Au,JL;Wientjes,MG;Bramer,SL
- 通讯作者:Bramer,SL
Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.
5-氟尿嘧啶、亚叶酸和葡萄糖二酸盐对大鼠结肠肿瘤外植体的影响。
- DOI:10.1007/bf00686481
- 发表时间:1992
- 期刊:
- 影响因子:3
- 作者:Schmittgen,TD;Koolemans-Beynen,A;Webb,TE;Rosol,TJ;Au,JL
- 通讯作者:Au,JL
Extraction of intracellular nucleosides and nucleotides with acetonitrile.
- DOI:10.1093/clinchem/35.1.48
- 发表时间:1989
- 期刊:
- 影响因子:9.3
- 作者:J. L. Au;M. Su;M. Wientjes
- 通讯作者:J. L. Au;M. Su;M. Wientjes
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessie L.-S. Au其他文献
Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer
- DOI:
10.1208/s12248-015-9785-x - 发表时间:
2015-06-19 - 期刊:
- 影响因子:3.700
- 作者:
Jessie L.-S. Au;Ze Lu;M. Guillaume Wientjes - 通讯作者:
M. Guillaume Wientjes
Delivery of siRNA Therapeutics: Barriers and Carriers
- DOI:
10.1208/s12248-010-9210-4 - 发表时间:
2010-06-11 - 期刊:
- 影响因子:3.700
- 作者:
Jie Wang;Ze Lu;M. Guillaume Wientjes;Jessie L.-S. Au - 通讯作者:
Jessie L.-S. Au
Drug Delivery and Transport to Solid Tumors
- DOI:
10.1023/a:1025785505977 - 发表时间:
2003-01-01 - 期刊:
- 影响因子:4.300
- 作者:
Seong Hoon Jang;M. Guillaume Wientjes;Dan Lu;Jessie L.-S. Au - 通讯作者:
Jessie L.-S. Au
Protection Against Chemotherapy-Induced Alopecia
- DOI:
10.1007/s11095-006-9105-3 - 发表时间:
2006-09-14 - 期刊:
- 影响因子:4.300
- 作者:
Jie Wang;Ze Lu;Jessie L.-S. Au - 通讯作者:
Jessie L.-S. Au
RAPID RELEASE PACLITAXEL NANOPARTICLES FOR INTRAVESICAL THERAPY IN DOGS WITH SPONTANEOUS BLADDER CANCER
- DOI:
10.1016/s0022-5347(09)61784-5 - 发表时间:
2009-04-01 - 期刊:
- 影响因子:
- 作者:
Jessie L.-S. Au;Ze Lu;Teng-Kuang Yeh;Greg Lyness;Ling Chen;Yan Xin;Andrea Miller;Melissa Ferry;Jake McKeegan;M. Guillaume Wientjes;Guillermo Couto;Francisco Alvarez-Berger;Carrie E. Eosarek - 通讯作者:
Carrie E. Eosarek
Jessie L.-S. Au的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessie L.-S. Au', 18)}}的其他基金
Targeting multiple signaling steps to achieve synergy
针对多个信号步骤以实现协同作用
- 批准号:
8637014 - 财政年份:2012
- 资助金额:
$ 7.12万 - 项目类别:
Targeting multiple signaling steps to achieve synergy
针对多个信号步骤以实现协同作用
- 批准号:
8546599 - 财政年份:2012
- 资助金额:
$ 7.12万 - 项目类别:
Targeting multiple signaling steps to achieve synergy
针对多个信号步骤以实现协同作用
- 批准号:
8848789 - 财政年份:2012
- 资助金额:
$ 7.12万 - 项目类别:
Combination chemo-siRNA gene therapy of nonmuscle-invading bladder cancer
非肌肉侵袭性膀胱癌的联合化疗-siRNA 基因治疗
- 批准号:
8121224 - 财政年份:2012
- 资助金额:
$ 7.12万 - 项目类别:
Targeting multiple signaling steps to achieve synergy
针对多个信号步骤以实现协同作用
- 批准号:
8448635 - 财政年份:2012
- 资助金额:
$ 7.12万 - 项目类别:
Capturing dynamic and inter-dependent biointerfaces in nanotechnology designs
在纳米技术设计中捕获动态且相互依赖的生物界面
- 批准号:
8536806 - 财政年份:2011
- 资助金额:
$ 7.12万 - 项目类别:
Capturing dynamic and inter-dependent biointerfaces in nanotechnology designs
在纳米技术设计中捕获动态且相互依赖的生物界面
- 批准号:
8723654 - 财政年份:2011
- 资助金额:
$ 7.12万 - 项目类别:
Multiscale computational models for developing combination cancer therapy
用于开发癌症联合疗法的多尺度计算模型
- 批准号:
8323312 - 财政年份:2011
- 资助金额:
$ 7.12万 - 项目类别:
Capturing dynamic and inter-dependent biointerfaces in nanotechnology designs
在纳米技术设计中捕获动态且相互依赖的生物界面
- 批准号:
8323331 - 财政年份:2011
- 资助金额:
$ 7.12万 - 项目类别:
相似海外基金
A novel mechanism of cell growth regulation by the intrinsically disordered protein, NPM1
内在无序蛋白 NPM1 调节细胞生长的新机制
- 批准号:
26440021 - 财政年份:2014
- 资助金额:
$ 7.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the mechanism of cell growth regulation by ST2 and its possible anti-cancerous effect.
ST2调节细胞生长的机制及其可能的抗癌作用研究。
- 批准号:
25460393 - 财政年份:2013
- 资助金额:
$ 7.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Mechanisms for cell growth regulation by Mnk-mediated translational control
Mnk 介导的翻译控制调节细胞生长的分子机制
- 批准号:
24590105 - 财政年份:2012
- 资助金额:
$ 7.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating Phosphatidylcholine Metabolism with Cell Growth Regulation
将磷脂酰胆碱代谢与细胞生长调节相结合
- 批准号:
221878 - 财政年份:2010
- 资助金额:
$ 7.12万 - 项目类别:
Operating Grants
UNDERSTANDING THE ROLES OF SMALL GTPASES IN CELL GROWTH REGULATION
了解小 GTP 酶在细胞生长调节中的作用
- 批准号:
7955176 - 财政年份:2009
- 资助金额:
$ 7.12万 - 项目类别:
Roles of the Golgi apparatus in cell growth regulation
高尔基体在细胞生长调节中的作用
- 批准号:
18570173 - 财政年份:2006
- 资助金额:
$ 7.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of cell growth regulation by small G proteins
小G蛋白调节细胞生长的机制
- 批准号:
17014061 - 财政年份:2005
- 资助金额:
$ 7.12万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
The role of Kaiso in cell growth regulation
Kaiso 在细胞生长调节中的作用
- 批准号:
302718-2004 - 财政年份:2004
- 资助金额:
$ 7.12万 - 项目类别:
Postgraduate Scholarships - Master's
Bone Cell Growth Regulation by Runx2/Cbfa1
Runx2/Cbfa1 调节骨细胞生长
- 批准号:
6619987 - 财政年份:2003
- 资助金额:
$ 7.12万 - 项目类别:
Bone Cell Growth Regulation by Runx2/Cbfa1
Runx2/Cbfa1 调节骨细胞生长
- 批准号:
6898940 - 财政年份:2003
- 资助金额:
$ 7.12万 - 项目类别: